IBIO Earnings
iBio Inc
$
0.729
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of iBio Inc(IBIO) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of iBio Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2024Q3 | 2024-05-13 | - | - | -0.71 | - | - | - | - | -1.62 | +7.03 |
IBIO Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, iBio Inc reported performance for FY2024Q3, announced on 2024-05-13. The company achieved an EPS of -0.71, compared to analyst estimates of by % . Revenue for the quarter reached 0.00 compared to expectations of 0.00 by % .
The stock price reacted with a -1.62% one-day change and a 7.03% five-day change following the earnings release. These movements reflect market reaction in iBio Inc growth trajectory and strategic initiatives.
IBIO Earnings Forecast
Looking ahead, iBio Inc(IBIO) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of -0.34.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming Q4 2025, revenue estimates have been adjusted No Change by 0% . These revisions correlate with a -0.14% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in iBio Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between IBIO's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Revenue Estimates for Q4 2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-0.14%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:333.33K
--
EPS Estimate-Annual FY 2025:-1.77
—
Stock Price0.73
IBIO Revenue and EPS Performance: A Historical Perspective
iBio Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2024Q3 (2024-05-13,):
EPS: -0.71 (Actual) vs. (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -1.62%(1-Day), 7.03%(5-Day)
(,):
EPS: (Actual) vs. (Estimate) (%)
Revenue: (Actual) vs. (Estimate) (%)
Price Reaction: %(1-Day), %(5-Day)
(,):
EPS: (Actual) vs. (Estimate) (%)
Revenue: (Actual) vs. (Estimate) (%)
Price Reaction: %(1-Day), %(5-Day)
Earnings Reaction
The chart below shows how IBIO performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IBIO sees a -8.79% change in stock price 10 days leading up to the earnings, and a +31.32% change 10 days following the report. On the earnings day itself, the stock moves by -1.62%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in MAR/2024, the stock changed 3.30% on the day following the earnings release and then changed by 31.32% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
No Data
People Also Watch
HYFM
Hydrofarm Holdings Group Inc
4.440
USD
+1.37%
CPSH
CPS Technologies Corp
3.240
USD
-6.09%
IGC
IGC Pharma Inc
0.355
USD
+2.90%
CTRM
Castor Maritime Inc
2.115
USD
+1.68%
IPW
iPower Inc
0.584
USD
+0.69%
PZG
Paramount Gold Nevada Corp
0.660
USD
-6.91%
CREX
Creative Realities Inc
2.730
USD
+14.23%
DRRX
DURECT Corp
1.900
USD
-0.52%
MRKR
Marker Therapeutics Inc
1.290
USD
+0.78%
NXGL
Nexgel Inc
2.400
USD
-11.44%
FAQ
What were the key highlights of IBIO’s latest earnings report for FY2024Q3?
IBIO reported its FY2024Q3 earnings on 2024-05-13, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was -0.71, surpassing the expected 0 by 0% . The stock experienced a -1.62% price change on the earnings day and a 7.03% change over the next five days, reflecting market reactions to the results.
How did IBIO’s stock price react after the FY2024Q3 earnings release?
What are the revenue and EPS estimates for IBIO for undefined?
How does IBIO’s stock price correlate with earnings forecast revisions?
What should investors expect from IBIO’s next earnings report?